N-([1,1′-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine | CAS:1246562-40-2

We serve N-([1,1′-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine CAS:1246562-40-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-([1,1'-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine

Chemical Name:N-([1,1'-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine
CAS.NO:1246562-40-2
Synonyms:N-(4-bromophenyl)-9,9-dimethyl-N-(4-phenylphenyl)fluoren-2-amine
2-Amino-N-[(1,1'-biphenyl)-4-yl]-N-(4-bromophenyl)-9,9-dimethylfluorene
Molecular Formula:C33H26BrN
Molecular Weight:516.47000
 
Physical and Chemical Properties:
Melting point:161ºC
 
Specification:
Appearance:White-yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like N-([1,1′-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-N-[(1,1′-biphenyl)-4-yl]-N-(4-bromophenyl)-9,9-dimethylfluorene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-([1,1′-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine Use and application,N-(4-bromophenyl)-9,9-dimethyl-N-(4-phenylphenyl)fluoren-2-amine technical grade,usp/ep/jp grade.


Related News: Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.1,5-Pentanedithiol manufacturer The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.N-[[(1,1-Dimethylethyl)Amino]Carbonyl]-3-Methyl-L-Valine supplier The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.cyclopropanecarboxylic acid vendor Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.